Biolife Solutions (BLFS) EBT (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of EBT data on file, last reported at $1.2 million in Q1 2026.

• On a quarterly basis, EBT rose 337.89% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was -$10.4 million, a 94.16% decrease from a year earlier, with the FY2025 full-year figure at -$12.1 million, down 36.93% from the prior year.
• EBT for Q1 2026 stood at $1.2 million, down from $3.4 million in the prior quarter.
• Over the last five years, EBT for BLFS reached as high as $90.7 million in Q4 2022 and fell as low as -$76.6 million in Q2 2022.
• Historically, EBT has averaged -$2.4 million across 5 years, with a median of -$3.2 million in 2024.
• Across the five-year window, EBT slumped 1538.52% in 2022 and jumped 616.84% in 2025, its largest moves.
• Year by year, EBT stood at $90.7 million in 2022, then slumped by 80.58% to $17.6 million in 2023, then slumped by 97.34% to $469000.0 in 2024, then soared by 616.84% to $3.4 million in 2025, then slumped by 62.88% to $1.2 million in 2026.
• Per Business Quant data, the three most recent EBT figures were $1.2 million in Q1 2026, $3.4 million in Q4 2025, and $703000.0 in Q3 2025.